Numerous studies have clearly shown the predictive significance of aberrant tau protein phosphorylation in the etiology of postoperative altered cognitive impairment and neuronal death in human disorders like Alzheimer’s disease (AD) (Monk et al., 2008; Newman et al., 2001). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.